Medix Inc. (TYO:331A)
Japan · Delayed Price · Currency is JPY 476.00
-1.00 (-0.21%)
Oct 6, 2026, 9:46 AM JST
Medix Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,493 | 3,601 | 5,484 | - | - | - | |
Market Cap Growth | -16.02% | -34.35% | - | - | - | - |
Enterprise Value | 533 | 340 | 2,442 | - | - | - |
Last Close Price | 477.00 | 467.18 | 647.18 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 8.63 | 8.26 | 6.83 | - | - | - |
PS Ratio | 0.82 | 0.85 | 1.32 | - | - | - |
PB Ratio | 0.98 | 1.01 | 1.68 | - | - | - |
P/TBV Ratio | 1.13 | 1.16 | 1.69 | - | - | - |
P/FCF Ratio | 16.17 | 16.67 | 11.31 | - | - | - |
P/OCF Ratio | 13.86 | 14.29 | 10.99 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.13 | 0.08 | 0.59 | - | - | - |
EV/EBITDA Ratio | 0.74 | 0.47 | 2.88 | - | - | - |
EV/EBIT Ratio | 0.81 | 0.52 | 3.05 | - | - | - |
EV/FCF Ratio | 2.47 | 1.57 | 5.04 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.23 | 0.23 | 0.04 | 0.16 | 0.29 | 0.35 |
Debt / EBITDA Ratio | 1.14 | 1.14 | 0.14 | - | - | 0.82 |
Debt / FCF Ratio | 3.81 | 3.81 | 0.25 | - | - | - |
Net Debt / Equity Ratio | -0.91 | -0.91 | -1.12 | -1.12 | -1.08 | -0.97 |
Net Debt / EBITDA Ratio | -4.50 | -4.50 | -4.31 | - | - | -2.29 |
Net Debt / FCF Ratio | -15.00 | -15.00 | -7.53 | - | - | - |
Asset Turnover | 0.59 | 0.59 | 0.66 | 0.74 | - | 2.89 |
Inventory Turnover | - | - | - | - | - | 207.24 |
Quick Ratio | 2.15 | 2.15 | 2.12 | 1.62 | 1.56 | 1.24 |
Current Ratio | 2.19 | 2.19 | 2.15 | 1.66 | 1.59 | 1.28 |
Return on Equity (ROE) | 12.71% | 12.71% | 29.60% | 25.17% | - | 10.72% |
Return on Assets (ROA) | 5.72% | 5.72% | 7.97% | 8.83% | - | 6.26% |
Return on Invested Capital (ROIC) | 289.42% | - | - | - | - | 122.67% |
Return on Capital Employed (ROCE) | 14.20% | 14.20% | 20.90% | 28.80% | 31.80% | 26.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 12.48% | 12.11% | 14.64% | - | - | - |
FCF Yield | 6.18% | 6.00% | 8.84% | - | - | - |
Dividend Yield | 3.99% | 3.85% | - | - | - | - |
Payout Ratio | 25.69% | 25.69% | 7.47% | - | - | - |
Buyback Yield / Dilution | -1.09% | -1.09% | -3.63% | 0.48% | - | - |
Total Shareholder Return | 2.89% | 2.76% | -3.63% | 0.48% | - | - |